Brain Microvascular Pericyte Pathology Linking Alzheimer's Disease to Diabetes

被引:0
|
作者
El-Ghazawi, Kareem [1 ]
Eyo, Ukpong B. [2 ,3 ]
Peirce, Shayn M. [1 ]
机构
[1] Univ Virginia, Dept Biomed Engn, Charlottesville, VA 22904 USA
[2] Univ Virginia, Ctr Brain Immunol, Dept Neurosci, Charlottesville, VA USA
[3] Glia Sch Med, Charlottesville, VA USA
关键词
Alzheimer's disease; blood-brain barrier; microcirculation; pericyte; type; 2; diabetes; AMYLOID-BETA; BARRIER DISRUPTION; SKELETAL-MUSCLE; TRANSGENIC MICE; MOUSE MODELS; CELLS; MICROGLIA; ACTIVATION; RAT; NEURODEGENERATION;
D O I
10.1111/micc.12877
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The brain microvasculature, which delivers oxygen and nutrients and forms a critical barrier protecting the central nervous system via capillaries, is deleteriously affected by both Alzheimer's disease (AD) and type 2 diabetes (T2D). T2D patients have an increased risk of developing AD, suggesting potentially related microvascular pathological mechanisms. Pericytes are an ideal cell type to study for functional links between AD and T2D. These specialized capillary-enwrapping cells regulate capillary density, lumen diameter, and blood flow. Pericytes also maintain endothelial tight junctions to ensure blood-brain barrier integrity, modulation of immune cell extravasation, and clearance of toxins. Changes in these phenomena have been observed in both AD and T2D, implicating "pericyte pathology" as a common feature of AD and T2D. This review examines the mechanisms of AD and T2D from the perspective of the brain microvasculature, highlighting how pericyte pathology contributes to both diseases. Our review identifies voids in understanding how AD and T2D negatively impact the brain microvasculature and suggests future studies to examine the intersections of these diseases.
引用
收藏
页数:17
相关论文
共 50 条
  • [31] Brain phosphoproteomic analysis identifies diabetes-related substrates in Alzheimer's disease pathology in older adults
    Capuano, Ana W.
    Sarsani, Vishal
    Tasaki, Shinya
    Mehta, Rupal I.
    Li, Jun
    Ahima, Rexford
    Arnold, Steven
    Bennett, David A.
    Petyuk, Vladislav
    Liang, Liming
    Arvanitakis, Zoe
    ALZHEIMERS & DEMENTIA, 2025, 21 (02)
  • [32] Brain pH and Alzheimer's pathology
    Ponto, Laura
    Schultz, Susan
    Jacob, Mathews
    Menda, Yusuf
    Wemmie, John
    Magnotta, Vincent
    JOURNAL OF NUCLEAR MEDICINE, 2014, 55
  • [33] Microvascular Alterations in Alzheimer's Disease
    Steinman, Joe
    Sun, Hong-Shuo
    Feng, Zhong-Ping
    FRONTIERS IN CELLULAR NEUROSCIENCE, 2021, 14
  • [34] Microvascular damage in Alzheimer's disease
    Butala, P
    Salloway, S
    Johanson, CE
    Gonzalez, L
    Tavares, R
    Hovanesian, V
    Donahue, JE
    Hulette, CM
    Vitek, MP
    Stopa, EG
    NEUROBIOLOGY OF AGING, 2004, 25 : S408 - S408
  • [35] Pericyte Loss and Alzheimer Disease
    不详
    JOURNAL OF NUCLEAR MEDICINE, 2014, 55 (02) : 17N - 17N
  • [36] The Role of Glucose Transporters in Brain Disease: Diabetes and Alzheimer's Disease
    Shah, Kaushik
    DeSilva, Shanal
    Abbruscato, Thomas
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2012, 13 (10): : 12629 - 12655
  • [37] Distribution of tau pathology in the brain stem of patients with Alzheimer's disease
    Ribalta, T
    Rey, MJ
    Blesa, R
    Tolosa, E
    Cardesa, A
    Ferrer, I
    BRAIN PATHOLOGY, 2000, 10 (04) : 514 - 514
  • [38] Visualizing pathology deposits in the living brain of patients with Alzheimer's disease
    Kepe, Vladimir
    Huang, Sung-Cheng
    Small, Gary W.
    Satyamurthy, Nagichettiar
    Barrio, Jorge R.
    AMYLOID, PRIONS, AND OTHER PROTEIN AGGREGATES, PT B, 2006, 412 : 144 - 160
  • [39] Changes in premorbid brain volume predict Alzheimer's disease pathology
    Silbert, LC
    Quinn, JF
    Moore, MM
    Corbridge, E
    Ball, MJ
    Murdoch, G
    Sexton, G
    Kaye, JA
    NEUROLOGY, 2003, 61 (04) : 487 - 492
  • [40] Apolipoprotein E alleles and brain vascular pathology in Alzheimer's disease
    Kalaria, RN
    Cohen, DL
    Premkumar, DRD
    NEUROBIOLOGY OF ALZHEIMER'S DISEASE, 1996, 777 : 266 - 270